|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ABCB11 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ABCB1 mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of ABCB1A mRNA Dichlorodiphenyl Dichloroethylene results in decreased expression of ABCB1 mRNA |
CTD |
PMID:15710169 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ABCB1B mRNA |
CTD |
PMID:15710169 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ABCC2 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ABCC8 mRNA |
CTD |
PMID:35457000 |
|
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases activity |
ISO |
Dichlorodiphenyl Dichloroethylene metabolite results in decreased activity of ABCG2 protein |
CTD |
PMID:23169446 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ABCG8 protein |
CTD |
PMID:27203212 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions |
ISO |
[Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACACA mRNA |
CTD |
PMID:25541407 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of ACADM protein |
CTD |
PMID:28397872 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of ACADS protein |
CTD |
PMID:28397872 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
multiple interactions |
EXP |
[Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ACE2 mRNA |
CTD |
PMID:30415545 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ACOX1 mRNA |
CTD |
PMID:25541407 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Actn1 |
actinin, alpha 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Acvr1c |
activin A receptor type 1C |
multiple interactions |
ISO |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ACVR1C mRNA |
CTD |
PMID:19422813 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
multiple interactions |
ISO |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ACVRL1 mRNA |
CTD |
PMID:19422813 |
|
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression increases secretion multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ADIPOQ mRNA Dichlorodiphenyl Dichloroethylene results in increased secretion of ADIPOQ protein [Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ADIPOQ protein |
CTD |
PMID:21044676 PMID:25541407 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of ADM mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Agt |
angiotensinogen |
multiple interactions increases expression |
EXP |
[Dichlorodiphenyl Dichloroethylene co-treated with Dietary Fats] results in increased expression of AGT mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of AGT mRNA |
CTD |
PMID:30415545 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1b |
angiotensin II receptor, type 1b |
multiple interactions |
EXP |
[Dichlorodiphenyl Dichloroethylene co-treated with Dietary Fats] affects the expression of AGTR1B mRNA |
CTD |
PMID:30415545 |
|
NCBI chr 2:102,844,969...102,920,232
Ensembl chr 2:102,844,969...102,920,232
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects response to substance increases expression multiple interactions |
ISO |
AHR polymorphism affects the susceptibility to Dichlorodiphenyl Dichloroethylene Dichlorodiphenyl Dichloroethylene results in increased expression of AHR mRNA TNF protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of AHR mRNA] AHR protein affects the susceptibility to Dichlorodiphenyl Dichloroethylene Dichlorodiphenyl Dichloroethylene results in increased expression of AHR mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of AHR protein |
CTD |
PMID:25084496 PMID:25316167 PMID:32721735 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Alk |
ALK receptor tyrosine kinase |
multiple interactions |
ISO |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ALK mRNA; [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in decreased expression of ALK mRNA |
CTD |
PMID:19422813 PMID:28263720 |
|
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] |
CTD |
PMID:29149346 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of AMPD3 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of APAF1 mRNA |
CTD |
PMID:25410718 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apoe |
apolipoprotein E |
increases response to substance |
ISO |
APOE gene polymorphism results in increased susceptibility to Dichlorodiphenyl Dichloroethylene |
CTD |
PMID:24473795 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of APP protein |
CTD |
PMID:24473795 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions affects binding increases activity increases expression |
ISO EXP |
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein modified form]; [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] promotes the reaction [AR protein mutant form binds to KLK3 enhancer]; [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased expression of KLK3 mRNA; [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of MAPK1 protein; [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of MAPK3 protein; [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of VASP protein; Dichlorodiphenyl Dichloroethylene affects the reaction [CGA protein results in increased expression of AR mRNA]; Dichlorodiphenyl Dichloroethylene affects the reaction [Dihydrotestosterone results in increased activity of AR protein modified form]; Dichlorodiphenyl Dichloroethylene analog inhibits the reaction [Metribolone results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene binds to and results in decreased activity of AR protein; Dichlorodiphenyl Dichloroethylene binds to and results in increased activity of AR protein; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Dihydrotestosterone co-treated with Estradiol] results in decreased expression of AR mRNA]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Dihydrotestosterone co-treated with Estradiol] results in decreased expression of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dihydrotestosterone binds to AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone affects the localization of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone binds to and results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone promotes the reaction [AR protein binds to KLK3 promoter]]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone results in increased expression of AR protein]; Dihydrotestosterone inhibits the reaction [Dichlorodiphenyl Dichloroethylene analog results in increased activity of AR protein] Dichlorodiphenyl Dichloroethylene binds to AR protein Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein; Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form Dichlorodiphenyl Dichloroethylene results in increased expression of AR mRNA Dichlorodiphenyl Dichloroethylene binds to and results in decreased activity of AR protein; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Androgens binds to AR protein] |
CTD |
PMID:7791873 PMID:9073609 PMID:9705896 PMID:10053169 PMID:10448550 PMID:10696776 PMID:11861974 PMID:12676605 PMID:14565775 PMID:14579009 PMID:15064155 PMID:15084347 PMID:15589981 PMID:16125883 PMID:18275596 PMID:18324785 PMID:18819937 PMID:21291947 PMID:21295777 PMID:21310686 PMID:21729750 PMID:25682698 PMID:26022396 PMID:27391359 PMID:28803809 PMID:33049310 More...
|
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg1 |
arginase 1 |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of ARG1 mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [IL4 protein results in increased expression of ARG1 mRNA] |
CTD |
PMID:26748080 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ARNT mRNA |
CTD |
PMID:32721735 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arx |
aristaless related homeobox |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ARX mRNA |
CTD |
PMID:36674557 |
|
NCBI chr X:58,016,233...58,028,149
Ensembl chr X:58,016,233...58,028,142
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
multiple interactions |
EXP |
[Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ASS1 mRNA |
CTD |
PMID:30415545 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atf3 |
activating transcription factor 3 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of ATF3 protein |
CTD |
PMID:27589886 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf6 |
activating transcription factor 6 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of ATF6 protein |
CTD |
PMID:27589886 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions |
ISO |
ATG7 protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein] |
CTD |
PMID:32721735 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Avp |
arginine vasopressin |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of AVP mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bace2 |
beta-secretase 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions increases expression |
EXP |
Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] |
CTD |
PMID:21281706 PMID:21384494 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of BAX protein Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA] |
CTD |
PMID:19545618 PMID:21281706 PMID:21384494 PMID:25410718 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of BCL2 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of BCL2 protein |
CTD |
PMID:19545618 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of BCL2L11 mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of BCL2L2 mRNA |
CTD |
PMID:21384494 |
|
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions affects expression |
ISO |
BECN1 protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein] Dichlorodiphenyl Dichloroethylene affects the expression of BECN1 mRNA |
CTD |
PMID:32721735 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bhlha15 |
basic helix-loop-helix family, member a15 |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in decreased expression of BHLHA15 mRNA |
CTD |
PMID:28263720 |
|
NCBI chr12:10,420,465...10,424,641
Ensembl chr12:10,420,467...10,424,713
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases cleavage |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased cleavage of BID protein |
CTD |
PMID:19545618 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bik |
BCL2-interacting killer |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of BIK mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of BRCA1 mRNA fulvestrant inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BRCA1 mRNA] |
CTD |
PMID:20206645 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of BTG2 protein |
CTD |
PMID:27589886 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA |
CTD |
PMID:25607892 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA |
CTD |
PMID:25607892 |
|
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cacna2d3 |
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr16:4,098,439...4,912,498
Ensembl chr16:4,098,445...4,912,351
|
|
G |
Cacnb1 |
calcium voltage-gated channel auxiliary subunit beta 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:82,998,182...83,018,838
Ensembl chr10:82,998,182...83,018,694
|
|
G |
Cacnb3 |
calcium voltage-gated channel auxiliary subunit beta 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074
|
|
G |
Cacng2 |
calcium voltage-gated channel auxiliary subunit gamma 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:109,572,838...109,698,516
Ensembl chr 7:109,574,459...109,697,227
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341
|
|
G |
Cacng7 |
calcium voltage-gated channel auxiliary subunit gamma 7 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calb2 |
calbindin 2 |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of CALB2 mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA |
CTD |
PMID:25607892 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA |
CTD |
PMID:25607892 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
|
|
G |
Capn1 |
calpain 1 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of CAPN1 mRNA |
CTD |
PMID:21384494 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Car2 |
carbonic anhydrase 2 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of CA2 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Card10 |
caspase recruitment domain family, member 10 |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of CARD10 mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 7:110,330,460...110,371,551
Ensembl chr 7:110,330,408...110,359,224
|
|
G |
Card6 |
caspase recruitment domain family, member 6 |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of CARD6 mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 2:54,194,343...54,206,902
Ensembl chr 2:54,195,739...54,206,846
|
|
G |
Cartpt |
CART prepropeptide |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in increased expression of CARTPT mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp12 |
caspase 12 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of CASP12 mRNA |
CTD |
PMID:21384494 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
increases activity increases expression affects expression multiple interactions |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein Dichlorodiphenyl Dichloroethylene results in increased expression of CASP3 mRNA Dichlorodiphenyl Dichloroethylene affects the expression of CASP3 protein ATG7 protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein]; BECN1 protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein]; diazepinylbenzoic acid inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein]; ethyl (5-(diethylglycyl)-10,11-dihydro-5H-dibenzo(b,f)azepin-3-yl)carbamate inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein]; RXRA mRNA promotes the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein]; RXRB mRNA promotes the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein] |
CTD |
PMID:19545618 PMID:19644561 PMID:20025943 PMID:21384494 PMID:24576310 PMID:25410718 PMID:26563996 PMID:32721735 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of CASP4 mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp8 |
caspase 8 |
decreases expression increases activity increases expression |
EXP ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of CASP8 protein Dichlorodiphenyl Dichloroethylene results in increased activity of CASP8 protein Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8 mRNA |
CTD |
PMID:19545618 PMID:19644561 PMID:20025943 PMID:21384494 PMID:24576310 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp8ap2 |
caspase 8 associated protein 2 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275
|
|
G |
Casp9 |
caspase 9 |
increases activity increases expression |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in increased activity of CASP9 protein Dichlorodiphenyl Dichloroethylene results in increased expression of CASP9 mRNA |
CTD |
PMID:19545618 PMID:21384494 PMID:24576310 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in decreased activity of CAT protein [Polychlorinated Biphenyls co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Chlordan co-treated with nonachlor] inhibits the reaction [Fish Oils results in increased expression of CAT mRNA] |
CTD |
PMID:25386960 PMID:28659405 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc85a |
coiled-coil domain containing 85A |
increases methylation |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased methylation of CCDC85A gene |
CTD |
PMID:30822522 |
|
NCBI chr14:102,126,574...102,359,207
Ensembl chr14:102,129,029...102,359,058
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein]; fulvestrant inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 mRNA]; GLI1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein] Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein |
CTD |
PMID:20206645 PMID:25386960 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of CD36 mRNA] |
CTD |
PMID:25541407 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd38 |
CD38 molecule |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of CD38 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd40lg |
CD40 ligand |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of CD40LG mRNA |
CTD |
PMID:24576310 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd44 |
CD44 molecule |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd81 |
Cd81 molecule |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [endotoxin, Escherichia coli results in increased expression of CD86 protein] |
CTD |
PMID:28412309 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of CDH2 protein Dichlorodiphenyl Dichloroethylene results in increased expression of CDH2 mRNA |
CTD |
PMID:23501609 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased activity of CEBPA protein |
CTD |
PMID:27589886 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased activity of CEBPB protein |
CTD |
PMID:27589886 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene affects the reaction [CGA protein results in increased expression of AR mRNA] |
CTD |
PMID:27391359 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Chga |
chromogranin A |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of CHRM2 mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of CHRNA3 mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Clock |
clock circadian regulator |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of CLOCK protein |
CTD |
PMID:27589886 |
|
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
|
|
G |
Clu |
clusterin |
increases expression multiple interactions |
EXP ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CLU mRNA Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dihydrotestosterone results in decreased expression of CLU mRNA] |
CTD |
PMID:9007049 PMID:21291947 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of CPT1A mRNA |
CTD |
PMID:28397872 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
multiple interactions |
EXP |
[Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CRABP1 mRNA |
CTD |
PMID:30415545 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased activity of CREB1 protein |
CTD |
PMID:27589886 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of CREBBP protein |
CTD |
PMID:22609851 PMID:27589886 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crem |
cAMP responsive element modulator |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of CREM protein |
CTD |
PMID:27589886 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
ISO EXP |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CRH mRNA [Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] affects the expression of CRH mRNA |
CTD |
PMID:32518293 PMID:34383603 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
multiple interactions |
ISO |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CRHR1 mRNA |
CTD |
PMID:32518293 |
|
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions affects activity increases activity |
ISO |
CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein]; CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein] Dichlorodiphenyl Dichloroethylene affects the activity of CTNNB1 protein Dichlorodiphenyl Dichloroethylene results in increased activity of CTNNB1 protein |
CTD |
PMID:25386960 PMID:27589886 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYBA mRNA |
CTD |
PMID:25386960 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions increases expression |
EXP |
Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CYCS mRNA] |
CTD |
PMID:21281706 PMID:21384494 PMID:25410718 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP ISO |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of CYP11A1 mRNA [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:32518293 PMID:34000504 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of CYP11B1 mRNA |
CTD |
PMID:34000504 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of CYP11B2 mRNA |
CTD |
PMID:34000504 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:34000504 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions increases activity decreases expression increases expression decreases activity |
ISO EXP |
[Dichlorodiphenyl Dichloroethylene co-treated with bisphenol A] results in decreased activity of CYP19A1 protein; [Dichlorodiphenyl Dichloroethylene co-treated with Chlordecone] results in increased activity of CYP19A1 protein; [Dichlorodiphenyl Dichloroethylene co-treated with FSHB protein] results in increased activity of CYP19A1 protein; [Dichlorodiphenyl Dichloroethylene co-treated with nonylphenol] results in increased activity of CYP19A1 protein; [Dichlorodiphenyl Dichloroethylene co-treated with o,p'-DDT] results in decreased activity of CYP19A1 protein; Dichlorodiphenyl Dichloroethylene results in increased expression of and results in increased activity of CYP19A1 protein Dichlorodiphenyl Dichloroethylene results in increased activity of CYP19A1 protein Dichlorodiphenyl Dichloroethylene results in decreased expression of CYP19A1 mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of CYP19A1 mRNA Dichlorodiphenyl Dichloroethylene results in decreased activity of CYP19A1 protein [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:12035542 PMID:15070871 PMID:16077170 PMID:17599374 PMID:20924025 PMID:25607892 More...
|
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression increases methylation |
EXP ISO |
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CYP1A1 mRNA; [Polychlorinated Biphenyls co-treated with DDT co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CYP1A1 mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of CYP1A1 Dichlorodiphenyl Dichloroethylene results in increased methylation of CYP1A1 gene |
CTD |
PMID:16036770 PMID:21512963 PMID:24878560 PMID:30822522 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP1B1 mRNA |
CTD |
PMID:16040568 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP27A1 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B1; Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B1 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B1 protein |
CTD |
PMID:12869653 PMID:21512963 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B6 mRNA [CYP2B6 gene SNP affects the susceptibility to DDT] which affects the abundance of Dichlorodiphenyl Dichloroethylene; CYP2B6 gene SNP affects the reaction [DDT results in increased abundance of Dichlorodiphenyl Dichloroethylene] |
CTD |
PMID:20686338 PMID:27839851 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP3A4 mRNA |
CTD |
PMID:20686338 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP3A23-3A1 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of CYP3A23-3A1 protein [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:12869653 PMID:24878560 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP7A1 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of CYP8B1 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dcc |
DCC netrin 1 receptor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA |
CTD |
PMID:25607892 |
|
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of DDIT3 protein |
CTD |
PMID:27589886 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
multiple interactions decreases expression |
ISO |
[Oleic Acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DGAT2 mRNA Dichlorodiphenyl Dichloroethylene results in decreased expression of DGAT2 mRNA |
CTD |
PMID:38092172 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of DHCR7 mRNA |
CTD |
PMID:34000504 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
multiple interactions |
EXP |
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DIO2 mRNA |
CTD |
PMID:24878560 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
multiple interactions |
ISO |
[Environmental Pollutants results in increased abundance of Dichlorodiphenyl Dichloroethylene] which results in increased methylation of DIO3 promoter |
CTD |
PMID:31272017 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dis3l |
DIS3-like exosome 3'-5' exoribonuclease |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of DIS3L mRNA; Dichlorodiphenyl Dichloroethylene results in decreased expression of DIS3L protein |
CTD |
PMID:32892578 |
|
NCBI chr 8:64,803,925...64,840,306
Ensembl chr 8:64,803,927...64,840,165
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dlgap3 |
DLG associated protein 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 5:139,491,972...139,562,625
Ensembl chr 5:139,492,947...139,562,625
|
|
G |
Dlgap4 |
DLG associated protein 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490
|
|
G |
Dmp1 |
dentin matrix acidic phosphoprotein 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of DMP1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr14:5,528,441...5,542,078
Ensembl chr14:5,528,431...5,539,323
|
|
G |
Dnm1 |
dynamin 1 |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of DNM1 mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 3:15,604,782...15,648,654
Ensembl chr 3:15,604,784...15,648,538
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of DNMT1 mRNA |
CTD |
PMID:30153481 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of DNMT3A mRNA |
CTD |
PMID:30153481 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Doc2a |
double C2 domain alpha |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030
|
|
G |
Dpp10 |
dipeptidyl peptidase like 10 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr13:34,584,420...36,269,292
Ensembl chr13:34,595,868...36,269,292
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
multiple interactions |
EXP |
[Dichlorodiphenyl Dichloroethylene co-treated with Dietary Fats] results in increased expression of DPP4 mRNA |
CTD |
PMID:28572628 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpp6 |
dipeptidyl peptidase like 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:7,591,009...8,508,532
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of EBP mRNA |
CTD |
PMID:16498641 |
|
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA |
CTD |
PMID:25607892 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Epha3 |
Eph receptor A3 |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of EPHA3 mRNA |
CTD |
PMID:28263720 |
|
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
|
|
G |
Epha8 |
Eph receptor A8 |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of EPHA8 mRNA |
CTD |
PMID:28263720 |
|
NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions |
ISO EXP |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ERBB3 mRNA [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA |
CTD |
PMID:19422813 PMID:25607892 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity multiple interactions affects binding decreases expression increases expression |
ISO EXP |
Dichlorodiphenyl Dichloroethylene analog results in increased activity of ESR1 protein; Dichlorodiphenyl Dichloroethylene results in increased activity of ESR1 protein Dichlorodiphenyl Dichloroethylene binds to and results in increased activity of ESR1 protein; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Dihydrotestosterone co-treated with Estradiol] results in decreased expression of ESR1 protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Estradiol binds to ESR1 protein]; Fulvestrant inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of ESR1 mRNA] Dichlorodiphenyl Dichloroethylene binds to ESR1 protein; Dichlorodiphenyl Dichloroethylene metabolite binds to ESR1 protein [Dichlorodiphenyl Dichloroethylene co-treated with beta-hexachlorocyclohexane] results in increased expression of ESR1 mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of ESR1 mRNA [o,p'-DDT co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Methoxychlor co-treated with Endosulfan co-treated with DDT] results in increased activity of ESR1 protein; [Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of ESR1 mRNA |
CTD |
PMID:9860891 PMID:10492897 PMID:14579009 PMID:15064155 PMID:16758953 PMID:17174995 PMID:18275596 PMID:18801367 PMID:19913605 PMID:20206645 PMID:21295777 PMID:26022396 PMID:29162470 PMID:32278787 PMID:33049310 PMID:34383603 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases activity affects binding multiple interactions |
ISO EXP |
Dichlorodiphenyl Dichloroethylene analog results in increased activity of ESR2 protein Dichlorodiphenyl Dichloroethylene binds to ESR2 protein Dichlorodiphenyl Dichloroethylene results in increased activity of ESR2 protein [o,p'-DDT co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Methoxychlor co-treated with Endosulfan co-treated with DDT] results in increased activity of ESR2 protein [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ESR2 mRNA |
CTD |
PMID:9860891 PMID:15064155 PMID:17713618 PMID:32518293 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of FABP1 mRNA |
CTD |
PMID:38092172 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA] |
CTD |
PMID:26200599 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of FAS mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of FAS protein |
CTD |
PMID:20025943 PMID:21384494 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG protein] Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG protein |
CTD |
PMID:16921742 PMID:19644561 PMID:20025943 PMID:21384494 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions increases expression decreases expression |
ISO |
[Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of FASN mRNA Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FASN mRNA] Dichlorodiphenyl Dichloroethylene results in increased expression of FASN protein Dichlorodiphenyl Dichloroethylene results in increased expression of FASN mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of FASN protein Dichlorodiphenyl Dichloroethylene results in decreased expression of FASN mRNA |
CTD |
PMID:25541407 PMID:26200599 PMID:27203212 PMID:28397872 PMID:38092172 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of FGF15 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of FGFR4 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
multiple interactions |
ISO |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FKBP5 mRNA |
CTD |
PMID:32518293 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Folh1 |
folate hydrolase 1 |
multiple interactions increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone results in decreased expression of FOLH1 mRNA] Dichlorodiphenyl Dichloroethylene results in increased expression of FOLH1 protein |
CTD |
PMID:25682698 |
|
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of FOS protein |
CTD |
PMID:27589886 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxc1 |
forkhead box C1 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of FOXC1 protein |
CTD |
PMID:27589886 |
|
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
|
|
G |
Foxc2 |
forkhead box C2 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of FOXC2 protein |
CTD |
PMID:27589886 |
|
NCBI chr19:49,186,034...49,188,736
Ensembl chr19:49,185,662...49,188,737
|
|
G |
Foxo3 |
forkhead box O3 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of FOXO3 protein |
CTD |
PMID:27589886 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxo4 |
forkhead box O4 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of FOXO4 protein |
CTD |
PMID:27589886 |
|
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
[Dichlorodiphenyl Dichloroethylene co-treated with FSHB protein] results in increased activity of CYP19A1 protein; Dichlorodiphenyl Dichloroethylene promotes the reaction [[FSHB protein results in increased activity of FSHR protein] which results in increased abundance of Cyclic AMP] |
CTD |
PMID:15070871 PMID:26895433 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
decreases expression increases expression multiple interactions |
EXP ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of FSHR protein Dichlorodiphenyl Dichloroethylene results in increased expression of FSHR mRNA Dichlorodiphenyl Dichloroethylene promotes the reaction [[FSHB protein results in increased activity of FSHR protein] which results in increased abundance of Cyclic AMP] |
CTD |
PMID:23501609 PMID:26895433 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Gabra4 |
gamma-aminobutyric acid type A receptor subunit alpha 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
|
|
G |
Gabrb1 |
gamma-aminobutyric acid type A receptor subunit beta1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr14:36,068,725...36,548,946
Ensembl chr14:36,080,393...36,548,948
|
|
G |
Gal |
galanin and GMAP prepropeptide |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of GAL mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galr1 |
galanin receptor 1 |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of GALR1 mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr18:75,772,021...75,787,577
Ensembl chr18:75,772,023...75,787,577
|
|
G |
Gck |
glucokinase |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of GCK mRNA |
CTD |
PMID:36674557 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC protein] Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC mRNA; Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC protein |
CTD |
PMID:25263748 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in decreased expression of GFRA1 mRNA |
CTD |
PMID:28263720 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of GIPC1 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr19:24,474,291...24,487,083
Ensembl chr19:24,453,123...24,486,997
|
|
G |
Gli1 |
GLI family zinc finger 1 |
multiple interactions increases expression |
ISO |
GLI1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein]; GLI1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein] Dichlorodiphenyl Dichloroethylene results in increased expression of GLI1 protein |
CTD |
PMID:25386960 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gls |
glutaminase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glyat |
glycine-N-acyltransferase |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of GLYAT mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
multiple interactions |
ISO |
[Dichlorodiphenyl Dichloroethylene co-treated with beta-hexachlorocyclohexane] results in increased expression of GNRH1 mRNA |
CTD |
PMID:16758953 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of GPX1 protein |
CTD |
PMID:31022254 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of GPX4 protein Dichlorodiphenyl Dichloroethylene results in increased expression of GPX4 mRNA |
CTD |
PMID:25410718 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Gria4 |
glutamate ionotropic receptor AMPA type subunit 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979
|
|
G |
Grid2 |
glutamate ionotropic receptor delta type subunit 2 |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of GRID2 mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 4:92,415,019...93,892,472
Ensembl chr 4:92,415,230...93,889,355
|
|
G |
Grik1 |
glutamate ionotropic receptor kainate type subunit 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
multiple interactions |
EXP ISO |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIN2B mRNA |
CTD |
PMID:25607892 PMID:32518293 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grin2d |
glutamate ionotropic receptor NMDA type subunit 2D |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of GRIN2D mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793
|
|
G |
Grip1 |
glutamate receptor interacting protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:54,934,856...55,592,274
Ensembl chr 7:54,934,250...55,592,273
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
affects activity |
ISO |
Dichlorodiphenyl Dichloroethylene affects the activity of GSK3B protein |
CTD |
PMID:25386960 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
multiple interactions decreases expression increases expression decreases methylation |
EXP |
[Dichlorodiphenyl Dichloroethylene results in decreased methylation of H19 gene] which results in increased expression of H19 mRNA Dichlorodiphenyl Dichloroethylene results in decreased expression of H19 mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of H19 mRNA |
CTD |
PMID:28867213 PMID:30153481 |
|
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
affects binding |
ISO |
Dichlorodiphenyl Dichloroethylene binds to HBA1 protein |
CTD |
PMID:32278787 |
|
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hbg1 |
hemoglobin subunit gamma 1 |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of HBG1 mRNA |
CTD |
PMID:16498641 |
|
NCBI chr 1:158,271,871...158,273,426
Ensembl chr 1:158,271,873...158,273,425
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of HNRNPH1 protein |
CTD |
PMID:26186133 |
|
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
|
|
G |
Hpgds |
hematopoietic prostaglandin D synthase |
affects binding |
ISO |
Dichlorodiphenyl Dichloroethylene binds to HPGDS protein |
CTD |
PMID:32278787 |
|
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
|
|
G |
Hrk |
harakiri, BCL2 interacting protein |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of HRK mRNA |
CTD |
PMID:24576310 |
|
NCBI chr12:38,387,484...38,409,652
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
ISO |
[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in increased expression of HSD3B1 mRNA; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in increased expression of HSD3B1 protein; STF-31 inhibits the reaction [[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in increased expression of HSD3B1 protein] |
CTD |
PMID:34311058 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of HSPB1 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
multiple interactions |
ISO |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of HTR1A mRNA |
CTD |
PMID:32518293 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
multiple interactions |
ISO |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HTR2A mRNA |
CTD |
PMID:32518293 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of IDI1 mRNA |
CTD |
PMID:16498641 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of ARG1 mRNA] |
CTD |
PMID:26748080 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone results in increased expression of IGF1 mRNA] |
CTD |
PMID:25682698 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions |
ISO |
[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in increased phosphorylation of IGF1R protein |
CTD |
PMID:33571556 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
decreases methylation decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased methylation of IGF2 gene Dichlorodiphenyl Dichloroethylene results in decreased expression of IGF2 mRNA |
CTD |
PMID:25187598 PMID:28867213 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression increases secretion decreases secretion |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of IL1B mRNA Dichlorodiphenyl Dichloroethylene results in increased secretion of IL1B protein Dichlorodiphenyl Dichloroethylene results in decreased secretion of IL1B protein |
CTD |
PMID:12007859 PMID:28572628 PMID:37236336 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:51,371,969...52,876,726
Ensembl chr X:51,378,215...52,876,772
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
[DDT co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IL4 protein Dichlorodiphenyl Dichloroethylene promotes the reaction [IL4 protein results in increased expression of ARG1 mRNA] |
CTD |
PMID:12696651 PMID:26748080 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Inha |
inhibin subunit alpha |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of INHA mRNA |
CTD |
PMID:34000504 |
|
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
|
|
G |
Inhbb |
inhibin subunit beta B |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of INHBB mRNA |
CTD |
PMID:16519141 PMID:19877505 |
|
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
|
|
G |
Ins1 |
insulin 1 |
increases secretion multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased secretion of INS1 protein [Glucose co-treated with Dichlorodiphenyl Dichloroethylene] results in increased secretion of INS1 protein |
CTD |
PMID:34225579 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions decreases expression |
ISO |
[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA; Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FASN mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of LEP mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SLC2A4 mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [Glucose results in increased secretion of INS protein] Dichlorodiphenyl Dichloroethylene results in decreased expression of INS2 mRNA |
CTD |
PMID:26200599 PMID:35457000 PMID:35563431 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Insl3 |
insulin-like 3 |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of INSL3 mRNA |
CTD |
PMID:34000504 |
|
NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560
|
|
G |
Isl1 |
ISL LIM homeobox 1 |
multiple interactions |
EXP |
[Dichlorodiphenyl Dichloroethylene co-treated with Dietary Fats] results in increased expression of ISL1 mRNA |
CTD |
PMID:28572628 |
|
NCBI chr 2:48,079,412...48,090,704
Ensembl chr 2:48,080,522...48,095,584
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
EXP |
[beta-hexachlorocyclohexane co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of JUN mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of JUN mRNA |
CTD |
PMID:18481421 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of KISS1 mRNA |
CTD |
PMID:34383603 |
|
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
multiple interactions |
ISO |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of KIT mRNA; [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of KIT mRNA |
CTD |
PMID:19422813 PMID:28263720 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions affects expression |
ISO |
[Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] promotes the reaction [AR protein mutant form binds to KLK3 enhancer]; [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased expression of KLK3 mRNA; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone promotes the reaction [AR protein binds to KLK3 promoter]]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone results in increased expression of KLK3 mRNA]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Metribolone results in increased expression of KLK3 protein] Dichlorodiphenyl Dichloroethylene affects the expression of KLK3 mRNA |
CTD |
PMID:18819937 PMID:25682698 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Krt18 |
keratin 18 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of KRT18 protein |
CTD |
PMID:26186133 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of LDLR mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
increases secretion multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased secretion of LEP protein Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of LEP mRNA] |
CTD |
PMID:21044676 PMID:26200599 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of LHCGR mRNA |
CTD |
PMID:34000504 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lhx4 |
LIM homeobox 4 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of LHX4 mRNA; Dichlorodiphenyl Dichloroethylene results in decreased expression of LHX4 protein |
CTD |
PMID:32892578 |
|
NCBI chr13:67,877,109...67,917,219
Ensembl chr13:67,877,109...67,927,003
|
|
G |
Lrrc2 |
leucine rich repeat containing 2 |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in decreased expression of LRRC2 mRNA |
CTD |
PMID:28263720 |
|
NCBI chr 8:110,936,119...110,969,189
Ensembl chr 8:110,938,165...110,969,185
|
|
G |
Lrrc7 |
leucine rich repeat containing 7 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:247,146,616...247,634,945
Ensembl chr 2:247,147,752...247,634,547
|
|
G |
Mafa |
MAF bZIP transcription factor A |
decreases expression increases expression |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of MAFA mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of MAFA mRNA |
CTD |
PMID:35457000 PMID:35563431 |
|
NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
affects expression increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene affects the expression of MAP1LC3A mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of MAP1LC3A protein |
CTD |
PMID:32721735 |
|
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of MAP1LC3B mRNA |
CTD |
PMID:32721735 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases activity multiple interactions increases phosphorylation |
EXP ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of MAPK1 protein [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of MAPK1 protein Dichlorodiphenyl Dichloroethylene results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:12523960 PMID:15531431 PMID:17174995 PMID:18819937 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
[Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of MAPK3 protein Dichlorodiphenyl Dichloroethylene results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:15531431 PMID:18819937 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mc2r |
melanocortin 2 receptor |
multiple interactions |
ISO |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of MC2R mRNA |
CTD |
PMID:32518293 |
|
NCBI chr18:62,001,980...62,015,567
Ensembl chr18:62,004,948...62,015,488
|
|
G |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:84,746,422...85,608,640
Ensembl chr 6:84,761,941...85,608,126
|
|
G |
Meg3 |
maternally expressed 3 |
multiple interactions decreases methylation increases expression |
EXP |
[Dichlorodiphenyl Dichloroethylene results in decreased methylation of MEG3 gene] which results in increased expression of MEG3 mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of MEG3 mRNA |
CTD |
PMID:30153481 |
|
NCBI chr 6:128,491,808...128,524,010
|
|
G |
Mertk |
MER proto-oncogene, tyrosine kinase |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in decreased expression of MERTK mRNA |
CTD |
PMID:28263720 |
|
NCBI chr 3:115,939,351...116,045,141
Ensembl chr 3:115,939,351...116,046,554
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in increased expression of and results in increased activity of MMP2 protein; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in increased expression of MMP2 mRNA; picropodophyllin inhibits the reaction [[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in increased activity of MMP2 protein] |
CTD |
PMID:33571556 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmrn1 |
multimerin 1 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of MMRN1 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 4:89,875,408...89,950,814
Ensembl chr 4:89,903,174...89,950,474
|
|
G |
Msmb |
microseminoprotein, beta |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of MSMB mRNA |
CTD |
PMID:15885261 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of MSMO1 mRNA |
CTD |
PMID:16498641 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of MT2A mRNA |
CTD |
PMID:15885261 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression multiple interactions increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein]; GLI1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein] Dichlorodiphenyl Dichloroethylene results in increased activity of MYC protein |
CTD |
PMID:25386960 PMID:27589886 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NCF1 mRNA Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of NCF1 mRNA] |
CTD |
PMID:25386960 PMID:28273962 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NCF2 mRNA |
CTD |
PMID:25386960 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Ncf4 |
neutrophil cytosolic factor 4 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NCF4 mRNA |
CTD |
PMID:25386960 |
|
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
|
|
G |
Nf1 |
neurofibromin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NF1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA; Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein] |
CTD |
PMID:25263748 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NFKB1 protein |
CTD |
PMID:19545618 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases phosphorylation |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased phosphorylation of NFKBIA protein |
CTD |
PMID:19545618 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlgn1 |
neuroligin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NLGN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:108,256,236...109,181,530
Ensembl chr 2:108,257,824...109,002,464
|
|
G |
Nmu |
neuromedin U |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of NMU mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
[Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOS1 mRNA; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of NOS1 mRNA] |
CTD |
PMID:28572628 PMID:30415545 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of NOS2 mRNA Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] |
CTD |
PMID:12007859 PMID:26748080 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NOS3 mRNA Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of NOS3 mRNA] |
CTD |
PMID:28273962 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Notch2 |
notch receptor 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NOTCH2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Notch3 |
notch receptor 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NOTCH3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Notch4 |
notch receptor 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
|
|
G |
Nox1 |
NADPH oxidase 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NOX1 mRNA |
CTD |
PMID:25386960 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of NR0B1 mRNA |
CTD |
PMID:34000504 |
|
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NR1H4 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression multiple interactions increases activity |
EXP ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NR1I2 mRNA Dichlorodiphenyl Dichloroethylene binds to and results in increased activity of NR1I2 protein Dichlorodiphenyl Dichloroethylene results in increased activity of NR1I2 protein |
CTD |
PMID:12869653 PMID:20686338 PMID:21115097 PMID:25680588 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases expression increases activity multiple interactions affects response to substance |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of NR1I3 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of NR1I3 protein Dichlorodiphenyl Dichloroethylene results in increased activity of NR1I3 protein Dichlorodiphenyl Dichloroethylene inhibits the reaction [Androstenols results in decreased activity of NR1I3 protein] NR1I3 protein affects the susceptibility to Dichlorodiphenyl Dichloroethylene |
CTD |
PMID:12869653 PMID:16929008 PMID:19746742 PMID:28927721 PMID:32721735 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions increases activity |
ISO EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] Dichlorodiphenyl Dichloroethylene results in increased activity of NR3C1 protein [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NR3C1 mRNA [Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of NR3C1 mRNA |
CTD |
PMID:26647222 PMID:27589886 PMID:32518293 PMID:34383603 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions decreases expression |
ISO EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] Dichlorodiphenyl Dichloroethylene results in decreased expression of NR3C2 mRNA [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NR3C2 mRNA |
CTD |
PMID:29149346 PMID:30415545 PMID:32518293 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of NR4A1 protein |
CTD |
PMID:27589886 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of NR4A2 protein |
CTD |
PMID:27589886 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRCAM mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Nrg1 |
neuregulin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nrxn1 |
neurexin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
|
|
G |
Nrxn2 |
neurexin 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRXN2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:203,726,420...203,842,301
Ensembl chr 1:203,735,753...203,842,297
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK1 mRNA |
CTD |
PMID:28263720 |
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
multiple interactions |
EXP ISO |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA |
CTD |
PMID:25607892 PMID:28263720 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Nup62 |
nucleoporin 62 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of NUP62 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of NUP62 protein |
CTD |
PMID:32721735 |
|
NCBI chr 1:95,298,995...95,314,902
Ensembl chr 1:95,295,526...95,315,174
|
|
G |
Or10al27 |
olfactory receptor family 10 subfamily AL member 27 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of OR10AL27 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr20:789,272...790,237
Ensembl chr20:761,025...765,744 Ensembl chr20:761,025...765,744
|
|
G |
Or13p4 |
olfactory receptor family 13 subfamily P member 4 |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of OR13P4 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 5:132,216,822...132,217,769
Ensembl chr 5:132,215,327...132,221,481
|
|
G |
Or9s23b |
olfactory receptor family 9 subfamily S member 23B |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of OR9S23B mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 9:93,117,328...93,118,299
Ensembl chr 9:93,115,232...93,123,441
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of ORM1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
multiple interactions |
ISO EXP |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of OXT mRNA [Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of OXT mRNA |
CTD |
PMID:32518293 PMID:34383603 |
|
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
|
|
G |
Oxtr |
oxytocin receptor |
multiple interactions |
ISO |
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of OXTR mRNA |
CTD |
PMID:32518293 |
|
NCBI chr 4:145,598,549...145,614,674
Ensembl chr 4:145,599,561...145,614,674
|
|
G |
Park7 |
Parkinsonism associated deglycase |
decreases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased activity of PARK7 protein |
CTD |
PMID:36842454 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of PARP1 protein |
CTD |
PMID:19545618 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA] |
CTD |
PMID:26647222 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
multiple interactions |
ISO |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of PDGFRA mRNA |
CTD |
PMID:19422813 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
ISO |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of PDGFRB mRNA; [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of PDGFRB mRNA |
CTD |
PMID:19422813 PMID:28263720 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pgr |
progesterone receptor |
affects binding multiple interactions increases expression |
ISO EXP |
Dichlorodiphenyl Dichloroethylene binds to PGR protein Dichlorodiphenyl Dichloroethylene inhibits the reaction [16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased activity of PGR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Progesterone binds to PGR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Progesterone results in increased expression of PGR protein]; fulvestrant inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of PGR mRNA] Dichlorodiphenyl Dichloroethylene results in increased expression of PGR mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of PGR protein [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PGR mRNA |
CTD |
PMID:14579009 PMID:16859517 PMID:18262749 PMID:20206645 PMID:25607892 PMID:26022396 PMID:32278787 More...
|
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Plin2 |
perilipin 2 |
multiple interactions |
ISO |
[Oleic Acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of PLIN2 mRNA; [Oleic Acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of PLIN2 protein; Dichlorodiphenyl Dichloroethylene promotes the reaction [Oleic Acid results in increased expression of PLIN2 protein] |
CTD |
PMID:38092172 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plxnd1 |
plexin D1 |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in decreased expression of PLXND1 mRNA |
CTD |
PMID:28263720 |
|
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
ISO EXP |
[Dichlorodiphenyl Dichloroethylene co-treated with beta-hexachlorocyclohexane] results in decreased expression of POMC mRNA [Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] affects the expression of POMC mRNA |
CTD |
PMID:16758953 PMID:34383603 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA |
CTD |
PMID:26200599 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of PPARGC1A protein |
CTD |
PMID:27589886 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of PPP1R1B mRNA |
CTD |
PMID:34383603 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PRKN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Prl |
prolactin |
increases secretion |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased secretion of PRL protein |
CTD |
PMID:17174995 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Ptch1 |
patched 1 |
increases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of PTCH1 mRNA |
CTD |
PMID:25386960 |
|
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of PTGS2 protein Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA] |
CTD |
PMID:19545618 PMID:23132776 PMID:26748080 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of PYCARD protein |
CTD |
PMID:27589886 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rack1 |
receptor for activated C kinase 1 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of RACK1 mRNA; Dichlorodiphenyl Dichloroethylene results in decreased expression of RACK1 protein |
CTD |
PMID:28412309 |
|
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
|
|
G |
Rdx |
radixin |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of RDX mRNA |
CTD |
PMID:16498641 |
|
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of REL protein |
CTD |
PMID:27589886 |
|
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects localization |
EXP |
Dichlorodiphenyl Dichloroethylene affects the localization of RELA protein |
CTD |
PMID:19644561 PMID:20025943 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Reln |
reelin |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of RELN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
|
|
G |
Ret |
ret proto-oncogene |
multiple interactions |
ISO |
[Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in decreased expression of RET mRNA |
CTD |
PMID:28263720 |
|
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
Retn |
resistin |
increases expression increases secretion |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of RETN mRNA Dichlorodiphenyl Dichloroethylene results in increased secretion of RETN protein |
CTD |
PMID:21044676 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of RIPK2 mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ROBO1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of RUNX1 protein |
CTD |
PMID:27589886 |
|
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of RUNX3 protein |
CTD |
PMID:27589886 |
|
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions increases expression |
EXP ISO |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of RXRA mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of RXRA mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of RXRA protein RXRA mRNA promotes the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein] |
CTD |
PMID:25607892 PMID:26563996 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Rxrb |
retinoid X receptor beta |
increases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of RXRB mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of RXRB protein RXRB mRNA promotes the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein] |
CTD |
PMID:26563996 |
|
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
|
|
G |
Ryr1 |
ryanodine receptor 1 |
affects activity |
ISO |
Dichlorodiphenyl Dichloroethylene affects the activity of RYR1 protein |
CTD |
PMID:31127943 |
|
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions |
EXP |
[Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of SCARB1 mRNA |
CTD |
PMID:34000504 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression multiple interactions increases expression |
EXP ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of SCD1 mRNA [Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SCD1 mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of SCD1 protein Dichlorodiphenyl Dichloroethylene results in increased expression of SCD1 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of SCD1 protein [Oleic Acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SCD mRNA Dichlorodiphenyl Dichloroethylene results in decreased expression of SCD mRNA |
CTD |
PMID:15885261 PMID:25541407 PMID:27203212 PMID:28397872 PMID:38092172 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scg2 |
secretogranin II |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of SCG2 mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
|
|
G |
Sh2d4a |
SH2 domain containing 4A |
increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of SH2D4A mRNA |
CTD |
PMID:15885261 |
|
NCBI chr16:21,339,010...21,409,360
Ensembl chr16:21,340,015...21,409,260
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SHANK2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
|
|
G |
Shbg |
sex hormone binding globulin |
multiple interactions increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene analog inhibits the reaction [Dihydrotestosterone binds to SHBG protein] Dichlorodiphenyl Dichloroethylene results in increased expression of SHBG mRNA |
CTD |
PMID:9171990 PMID:16380112 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Slc10a2 |
solute carrier family 10 member 2 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC10A2 mRNA |
CTD |
PMID:28392238 |
|
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
|
|
G |
Slc16a2 |
solute carrier family 16 member 2 |
multiple interactions |
ISO |
[Environmental Pollutants results in increased abundance of Dichlorodiphenyl Dichloroethylene] which results in increased methylation of SLC16A2 promoter |
CTD |
PMID:31272017 |
|
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc1a6 |
solute carrier family 1 member 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:10,841,836...10,870,424
Ensembl chr 7:10,841,837...10,870,449
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC2A1 mRNA |
CTD |
PMID:36674557 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in decreased expression of SLC2A4 mRNA] [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in decreased expression of SLC2A4 mRNA; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in decreased expression of SLC2A4 protein; Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SLC2A4 mRNA]; STF-31 inhibits the reaction [[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in decreased expression of SLC2A4 mRNA]; STF-31 inhibits the reaction [[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Hexachlorobenzene] results in decreased expression of SLC2A4 protein] |
CTD |
PMID:25541407 PMID:26200599 PMID:34311058 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc51a |
solute carrier family 51 member A |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC51A mRNA |
CTD |
PMID:28392238 |
|
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
|
|
G |
Slc51b |
SLC51 subunit beta |
decreases expression |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC51B mRNA |
CTD |
PMID:28392238 |
|
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
multiple interactions |
EXP ISO |
[Dichlorodiphenyl Dichloroethylene co-treated with Estradiol] promotes the reaction [SLC6A3 protein affects the export of Dopamine]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [SLC6A3 protein affects the export of Dopamine] Dichlorodiphenyl Dichloroethylene inhibits the reaction [DAT protein results in increased uptake of Dopamine] |
CTD |
PMID:18533268 PMID:19479021 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slit1 |
slit guidance ligand 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLIT1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127
|
|
G |
Smarcb1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of SMARCB1 protein |
CTD |
PMID:27589886 |
|
NCBI chr20:12,741,164...12,763,616
Ensembl chr20:12,741,477...12,763,620
|
|
G |
Snap25 |
synaptosome associated protein 25 |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of SNAP25 mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression multiple interactions |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of SOD1 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of SOD1 protein [Polychlorinated Biphenyls co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Chlordan co-treated with nonachlor] inhibits the reaction [Fish Oils results in increased expression of SOD1 mRNA] |
CTD |
PMID:19545618 PMID:28659405 PMID:31022254 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
EXP |
Dietary Fats inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of SOD2 protein]; Dietary Fats promotes the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of SOD2 protein] |
CTD |
PMID:31022254 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sptbn2 |
spectrin, beta, non-erythrocytic 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SPTBN2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:202,002,970...202,045,343
Ensembl chr 1:202,002,970...202,044,283
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased activity of SRD5A2 protein |
CTD |
PMID:17218080 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions increases expression decreases expression |
ISO |
[Oleic Acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SREBF1 mRNA; Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mRNA] Dichlorodiphenyl Dichloroethylene results in increased expression of SREBF1 protein Dichlorodiphenyl Dichloroethylene results in decreased expression of SREBF1 mRNA |
CTD |
PMID:26200599 PMID:27203212 PMID:38092172 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Sst |
somatostatin |
multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of SST mRNA] |
CTD |
PMID:28572628 |
|
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of STAR mRNA [Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of STAR mRNA |
CTD |
PMID:16498641 PMID:34000504 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in decreased activity of STAT3 protein |
CTD |
PMID:27589886 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of STAT5B protein |
CTD |
PMID:27589886 |
|
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Stmn2 |
stathmin 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:93,204,690...93,252,011
Ensembl chr 2:93,204,692...93,252,011
|
|
G |
Sts |
steroid sulfatase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of STS mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
|
|
G |
Stxbp1 |
syntaxin binding protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STXBP1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:16,076,725...16,138,431
Ensembl chr 3:16,076,391...16,138,369
|
|
G |
Syngap1 |
synaptic Ras GTPase activating protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of SYNGAP1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:5,026,366...5,056,659
Ensembl chr20:5,026,364...5,056,672
|
|
G |
Syp |
synaptophysin |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of SYP mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Tf |
transferrin |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of TF mRNA |
CTD |
PMID:16380112 PMID:16519141 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tfam |
transcription factor A, mitochondrial |
increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased activity of TFAM protein |
CTD |
PMID:27589886 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression multiple interactions |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of TFF1 mRNA [Dichlorodiphenyl Dichloroethylene co-treated with Dihydrotestosterone co-treated with Estradiol] results in increased expression of TFF1 mRNA; Fulvestrant inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of TFF1 mRNA] |
CTD |
PMID:18275596 PMID:20206645 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tg |
thyroglobulin |
multiple interactions |
EXP |
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of TG protein |
CTD |
PMID:24878560 |
|
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TGFB1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of TH mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thra |
thyroid hormone receptor alpha |
increases expression multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of THRA mRNA [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of THRA mRNA |
CTD |
PMID:21512963 PMID:24878560 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
increases expression multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene results in increased expression of THRB mRNA [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of THRB mRNA |
CTD |
PMID:21512963 PMID:24878560 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression increases expression multiple interactions |
ISO EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of TNF mRNA Dichlorodiphenyl Dichloroethylene results in increased expression of TNF protein Dichlorodiphenyl Dichloroethylene results in increased expression of TNF mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of TNF protein Dichlorodiphenyl Dichloroethylene inhibits the reaction [endotoxin, Escherichia coli results in increased expression of TNF protein]; TNF protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of AHR mRNA] |
CTD |
PMID:12007859 PMID:19545618 PMID:24576310 PMID:25316167 PMID:28412309 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of TNFRSF11B mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of TNFRSF1B mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tnfrsf22 |
tumor necrosis factor receptor superfamily, member 22 |
affects expression |
EXP |
Dichlorodiphenyl Dichloroethylene affects the expression of TNFRSF10B mRNA |
CTD |
PMID:24576310 |
|
NCBI chr 1:198,840,452...198,860,713
Ensembl chr 1:198,840,453...198,856,309
|
|
G |
Tp53 |
tumor protein p53 |
increases expression increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene results in increased expression of TP53 mRNA Dichlorodiphenyl Dichloroethylene results in increased activity of TP53 protein |
CTD |
PMID:19545618 PMID:27589886 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trhr |
thyrotropin releasing hormone receptor |
multiple interactions |
EXP |
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TRHR mRNA |
CTD |
PMID:24878560 |
|
NCBI chr 7:75,348,672...75,393,310
Ensembl chr 7:75,348,672...75,393,309
|
|
G |
Tsc2 |
TSC complex subunit 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TSC2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions increases activity |
ISO |
Dichlorodiphenyl Dichloroethylene inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] Dichlorodiphenyl Dichloroethylene results in increased activity of TSC22D3 protein |
CTD |
PMID:26647222 PMID:27589886 |
|
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
EXP ISO |
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of TSHB protein Dichlorodiphenyl Dichloroethylene affects the expression of and affects the secretion of TSHB protein |
CTD |
PMID:19750101 PMID:24878560 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Ttr |
transthyretin |
decreases expression multiple interactions |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of TTR protein [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of TTR protein |
CTD |
PMID:21512963 PMID:24878560 |
|
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions increases expression |
EXP |
Dichlorodiphenyl Dichloroethylene promotes the reaction [Dietary Fats results in increased expression of UCP2 mRNA]; Dichlorodiphenyl Dichloroethylene promotes the reaction [Dietary Fats results in increased expression of UCP2 protein]; Dietary Fats inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of UCP2 mRNA]; Dietary Fats inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of UCP2 protein] Dichlorodiphenyl Dichloroethylene results in increased expression of UCP2 mRNA; Dichlorodiphenyl Dichloroethylene results in increased expression of UCP2 protein |
CTD |
PMID:31022254 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
multiple interactions |
EXP |
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of UGT2B17 mRNA |
CTD |
PMID:24878560 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Unc5b |
unc-5 netrin receptor B |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of UNC5B mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
multiple interactions |
ISO |
[Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of VASP protein |
CTD |
PMID:18819937 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|
G |
Vim |
vimentin |
decreases expression |
EXP |
Dichlorodiphenyl Dichloroethylene results in decreased expression of VIM protein |
CTD |
PMID:23501609 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|